Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-25,000
Closed -$247K 796
2022
Q2
$247K Hold
25,000
0.02% 190
2022
Q1
$247K Sell
25,000
-167,000
-87% -$1.65M 0.02% 221
2021
Q4
$1.91M Buy
+192,000
New +$1.9M 0.17% 109
2021
Q3
Sell
-33,915
Closed -$343K 732
2021
Q2
$343K Buy
+33,915
New +$343K 0.02% 220

Other funds holding AKLI

Cowen and Company's AKLI Position: Q3 2022 in Review

Cowen and Company sold out of Akili Inc (AKLI) in Q3 2022, closing a stake of 25,000 shares — an estimated $247K sold.

Cowen and Company first reported a position in AKLI in Q2 2021 and held it in 4 quarters. The position peaked at $1.91M in Q4 2021. 25 funds tracked by Wall St. Rank hold AKLI as of Q3 2022.

  • Cowen and Company reported no remaining Akili Inc position as of Q3 2022 after selling out during the quarter.
  • Cowen and Company sold 25,000 Akili Inc shares in Q3 2022, an estimated $247K.
  • Cowen and Company first reported a position in Akili Inc in Q2 2021 and held it in 4 quarters.
  • Cowen and Company's Akili Inc position peaked at $1.91M in Q4 2021.
  • 25 funds tracked by Wall St. Rank held Akili Inc as of Q3 2022.

Based on Cowen and Company's 13F filing for Q3 2022, filed 14 Nov 2022.